27.20
price down icon3.82%   -1.08
pre-market  プレマーケット:  27.58   0.38   +1.40%
loading
前日終値:
$28.28
開ける:
$28.57
24時間の取引高:
1.36M
Relative Volume:
1.64
時価総額:
$1.63B
収益:
$439.00K
当期純損益:
$-105.64M
株価収益率:
-15.11
EPS:
-1.8
ネットキャッシュフロー:
$-60.70M
1週間 パフォーマンス:
+5.22%
1か月 パフォーマンス:
+16.19%
6か月 パフォーマンス:
-5.19%
1年 パフォーマンス:
-44.95%
1日の値動き範囲:
Value
$27.02
$29.09
1週間の範囲:
Value
$25.18
$29.09
52週間の値動き範囲:
Value
$21.73
$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Name
名前
Janux Therapeutics Inc
Name
セクター
Healthcare (1140)
Name
電話
(858) 751-4493
Name
住所
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Name
職員
103
Name
Twitter
Name
次回の収益日
2024-08-06
Name
最新のSEC提出書
Name
JANX's Discussions on Twitter

JANX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JANX
Janux Therapeutics Inc
27.20 1.55B 439.00K -105.64M -60.70M -1.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-17 開始されました Barclays Overweight
2025-09-10 開始されました Stifel Buy
2025-09-10 開始されました Truist Buy
2025-09-04 開始されました Guggenheim Buy
2025-08-19 開始されました Piper Sandler Overweight
2025-07-11 開始されました Raymond James Outperform
2024-12-03 繰り返されました BTIG Research Buy
2024-12-03 繰り返されました H.C. Wainwright Buy
2024-11-22 開始されました Leerink Partners Outperform
2024-10-24 開始されました UBS Buy
2024-09-06 開始されました Stifel Buy
2024-05-30 開始されました Scotiabank Sector Perform
2024-03-21 開始されました BTIG Research Buy
2024-03-20 開始されました Cantor Fitzgerald Overweight
2023-04-06 開始されました Wedbush Outperform
2022-11-14 開始されました William Blair Outperform
すべてを表示

Janux Therapeutics Inc (JANX) 最新ニュース

pulisher
Oct 15, 2025

Can Janux Therapeutics Inc. stock surprise with earnings upsideForecast Cut & AI Forecast for Swing Trade Picks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Real time alert setup for Janux Therapeutics Inc. performanceQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Is Janux Therapeutics Inc. stock attractive for income investorsJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Can trapped investors hope for a rebound in Janux Therapeutics Inc.Market Performance Report & Stock Portfolio Risk Control - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is Janux Therapeutics Inc. stock poised for growthWeekly Loss Report & High Return Stock Watch Alerts - newser.com

Oct 14, 2025
pulisher
Oct 12, 2025

Janux Therapeutics (JANX) Is Up 10.5% After Positive Pipeline Updates and Analyst EPS Revisions – Has the Bull Case Changed? - Sahm

Oct 12, 2025
pulisher
Oct 10, 2025

Why Janux Therapeutics (JANX) Is Up 10.5% After Pipeline Progress Fuels Optimism for Prostate Cancer Therapies - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Trend analysis for Janux Therapeutics Inc. this weekPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains? - Nasdaq

Oct 09, 2025
pulisher
Oct 09, 2025

What drives Janux Therapeutics Inc stock priceEarnings Per Share Trends & Rapid Portfolio Gain - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Janux Therapeutics (NASDAQ:JANX) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Visual trend scoring systems applied to Janux Therapeutics Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Janux Therapeutics (NASDAQ:JANX) Is In A Good Position To Deliver On Growth Plans - Sahm

Oct 08, 2025
pulisher
Oct 07, 2025

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring the 245% Upside Potential in Biotech - DirectorsTalk Interviews

Oct 07, 2025
pulisher
Oct 06, 2025

How hedge fund analytics apply to Janux Therapeutics Inc. stockWeekly Trade Review & Capital Protection Trading Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will a bounce in Janux Therapeutics Inc. offer an exitMarket Movement Recap & AI Enhanced Trading Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How geopolitical tensions affect Janux Therapeutics Inc. stock2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Janux Therapeutics Inc. recovery potential after sell offDollar Strength & Real-Time Volume Surge Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Leading vs lagging indicators on Janux Therapeutics Inc. performanceJuly 2025 Outlook & Community Supported Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Janux Therapeutics Inc (JANX) Gets a Buy from Bank of America Securities - The Globe and Mail

Oct 04, 2025
pulisher
Oct 03, 2025

BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating - 富途牛牛

Oct 03, 2025
pulisher
Oct 03, 2025

What earnings revisions data tells us about Janux Therapeutics Inc.Recession Risk & Daily Profit Maximizing Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using data tools to time your Janux Therapeutics Inc. exitWeekly Trend Summary & High Accuracy Trade Signal Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 01:15:11 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $78.31 Average PT from Brokerages - Defense World

Oct 02, 2025
pulisher
Oct 01, 2025

Will Q4 Earnings Be a Catalyst for Jash Engineering LimitedDay Trading Setups & Affordable Investment Tips - earlytimes.in

Oct 01, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 03:27:23 - newser.com

Sep 29, 2025

Janux Therapeutics Inc (JANX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Janux Therapeutics Inc (JANX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Meyer Andrew Hollman
Chief Business Officer
May 01 '25
Sale
32.03
3,333
106,745
82,139
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
大文字化:     |  ボリューム (24 時間):